Anika to Participate in the Canaccord Genuity Musculoskeletal Conference

Rhea-AI Summary

Anika Therapeutics, trading as ANIK on NASDAQ, will participate in the Canaccord Genuity Musculoskeletal Conference in Chicago on March 22, 2022, at 9:30 a.m. CT. The event will be available via live audio webcast on Anika's Investor Relations website, with an archive accessible later. Anika is known for its innovative joint preservation therapies and focuses on early intervention orthopedic care, particularly for osteoarthritis, sports medicine, and regenerative solutions. The company's headquarters are located near Boston, Massachusetts.

BEDFORD, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate at the Canaccord Genuity Musculoskeletal Conference in Chicago, IL on Tuesday, March 22, 2022 at 9:30 a.m. CT.

A live audio webcast will be available in the Investor Relations section of Anika’s website, www.anika.com. An audio archive of the session will also be available on the website.

About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, sports medicine soft tissue repair and bone preserving joint technologies, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.

ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc.

For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Vice President, Investor Relations, ESG and Corporate Communications
investorrelations@anika.com

FAQ

When will Anika Therapeutics present at the Canaccord Genuity Musculoskeletal Conference?

Anika Therapeutics will present at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022, at 9:30 a.m. CT.

How can I access the live webcast of Anika Therapeutics' presentation?

The live audio webcast of Anika Therapeutics' presentation can be accessed through the Investor Relations section of their website.

What is the focus of Anika Therapeutics in the orthopedic field?

Anika Therapeutics is focused on joint preservation, including therapies for osteoarthritis pain management, regenerative solutions, and sports medicine.

Where is Anika Therapeutics headquartered?

Anika Therapeutics is headquartered outside of Boston, Massachusetts.

What is the ticker symbol for Anika Therapeutics?

The ticker symbol for Anika Therapeutics is ANIK, traded on NASDAQ.